001     278654
005     20250601001324.0
024 7 _ |a 10.1038/s41467-025-59338-5
|2 doi
024 7 _ |a pmid:40360474
|2 pmid
024 7 _ |a pmc:PMC12075517
|2 pmc
024 7 _ |a altmetric:177061629
|2 altmetric
037 _ _ |a DZNE-2025-00610
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Acharya, Dhiraj
|b 0
245 _ _ |a TRIM23 mediates cGAS-induced autophagy in anti-HSV defense.
260 _ _ |a [London]
|c 2025
|b Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1748428534_8082
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The cGAS-STING pathway, well-known to elicit interferon (IFN) responses, is also a key inducer of autophagy upon virus infection or other stimuli. Whereas the mediators for cGAS-induced IFN responses are well characterized, much less is known about how cGAS elicits autophagy. Here, we report that TRIM23, a unique TRIM protein harboring both ubiquitin E3 ligase and GTPase activity, is crucial for cGAS-STING-dependent antiviral autophagy. Genetic ablation of TRIM23 impairs autophagic control of HSV-1 infection. HSV-1 infection or cGAS-STING stimulation induces TBK1-mediated TRIM23 phosphorylation at S39, which triggers TRIM23 autoubiquitination and GTPase activity and ultimately elicits autophagy. Fibroblasts from a patient with herpes simplex encephalitis heterozygous for a dominant-negative, kinase-inactivating TBK1 mutation fail to activate autophagy by TRIM23 and cGAS-STING. Our results thus identify the cGAS-STING-TBK1-TRIM23 axis as a key autophagy defense pathway and may stimulate new therapeutic interventions for viral or inflammatory diseases.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Nucleotidyltransferases
|0 EC 2.7.7.-
|2 NLM Chemicals
650 _ 7 |a Protein Serine-Threonine Kinases
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a Membrane Proteins
|2 NLM Chemicals
650 _ 7 |a cGAS protein, human
|0 EC 2.7.7.-
|2 NLM Chemicals
650 _ 7 |a TBK1 protein, human
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a STING1 protein, human
|2 NLM Chemicals
650 _ 7 |a Ubiquitin-Protein Ligases
|0 EC 2.3.2.27
|2 NLM Chemicals
650 _ 7 |a cGAS protein, mouse
|0 EC 2.7.7.-
|2 NLM Chemicals
650 _ 2 |a Autophagy: immunology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Nucleotidyltransferases: metabolism
|2 MeSH
650 _ 2 |a Nucleotidyltransferases: genetics
|2 MeSH
650 _ 2 |a Nucleotidyltransferases: immunology
|2 MeSH
650 _ 2 |a Herpesvirus 1, Human: immunology
|2 MeSH
650 _ 2 |a Herpesvirus 1, Human: physiology
|2 MeSH
650 _ 2 |a Protein Serine-Threonine Kinases: metabolism
|2 MeSH
650 _ 2 |a Protein Serine-Threonine Kinases: genetics
|2 MeSH
650 _ 2 |a Membrane Proteins: metabolism
|2 MeSH
650 _ 2 |a Membrane Proteins: genetics
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Phosphorylation
|2 MeSH
650 _ 2 |a Fibroblasts: metabolism
|2 MeSH
650 _ 2 |a Fibroblasts: virology
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Ubiquitin-Protein Ligases: metabolism
|2 MeSH
650 _ 2 |a Ubiquitin-Protein Ligases: genetics
|2 MeSH
650 _ 2 |a Herpes Simplex: immunology
|2 MeSH
650 _ 2 |a Herpes Simplex: virology
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a Signal Transduction
|2 MeSH
650 _ 2 |a Ubiquitination
|2 MeSH
700 1 _ |a Sayyad, Zuberwasim
|0 0000-0003-1799-7604
|b 1
700 1 _ |a Hoenigsperger, Helene
|0 P:(DE-2719)9003500
|b 2
|u dzne
700 1 _ |a Hirschenberger, Maximilian
|0 P:(DE-2719)9003503
|b 3
|u dzne
700 1 _ |a Zurenski, Matthew
|b 4
700 1 _ |a Balakrishnan, Kannan
|b 5
700 1 _ |a Zhu, Junji
|0 0000-0003-2968-180X
|b 6
700 1 _ |a Gableske, Sebastian
|b 7
700 1 _ |a Kato, Jiro
|0 0000-0003-0318-1794
|b 8
700 1 _ |a Zhang, Shen-Ying
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Casanova, Jean-Laurent
|b 10
700 1 _ |a Moss, Joel
|b 11
700 1 _ |a Sparrer, Konstantin M J
|0 P:(DE-2719)9003481
|b 12
700 1 _ |a Gack, Michaela U
|0 0000-0002-2163-2598
|b 13
773 _ _ |a 10.1038/s41467-025-59338-5
|g Vol. 16, no. 1, p. 4418
|0 PERI:(DE-600)2553671-0
|n 1
|p 4418
|t Nature Communications
|v 16
|y 2025
|x 2041-1723
856 4 _ |u https://pub.dzne.de/record/278654/files/DZNE-2025-00610%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/278654/files/DZNE-2025-00610.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/278654/files/DZNE-2025-00610.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:278654
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-2719)9003500
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-2719)9003503
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)9003481
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-02
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2025-01-02
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2025-01-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2025-01-02
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-01-30T07:48:07Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-01-30T07:48:07Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2024-01-30T07:48:07Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
920 1 _ |0 I:(DE-2719)1910003
|k AG Sparrer
|l Neurovirology and Neuroinflammation
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1910003
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21